Biotia, founded at the Jacobs Technion-Cornell Institute Runway Startup Postdoc Program, announced a $2.4 million seed round led by Falcon III Ventures.
Biotia is a health tech company that leverages next-generation DNA sequencing (NGS) and artificial intelligence (AI) software to help hospitals detect and diagnose infectious diseases.
According to a release issued by the company, “The funds will be used to further develop and implement Biotia’s diagnostic testing methods, including its AI-based software Chelsea™, offer myriad advantages over the current approaches in hospitals, such as limited PCR panels or culturing.”
Media Highlights
NY Daily News
Let tech build NYC’s future, todayCommercial Observer
Proptech and New York’s Next Mayor: An Unprecedented Opportunity LoomsRELATED STORIES
Do Robots Need Clothes?
Yes, says a team from Cornell Tech – but for functional fashion. …
Runway Q&A: Spacemate
Spacemate, a Runway Startup at the Jacobs Technion-Cornell Institute, is a data-driven …
New Cornell Tech Course Helping Cities Reboot
By Melanie Lefkowitz A platform that uses machine learning, sensors and location data …